Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
2Activity
0 of .
Results for:
No results containing your search query
P. 1
LINCARE HOLDINGS INC 10-K (Annual Reports) 2009-02-25

LINCARE HOLDINGS INC 10-K (Annual Reports) 2009-02-25

Ratings: (0)|Views: 404 |Likes:
Published by http://secwatch.com
LINCARE HOLDINGS INC 10-K (Annual Reports) 2009-02-25
LINCARE HOLDINGS INC 10-K (Annual Reports) 2009-02-25

More info:

Published by: http://secwatch.com on Mar 03, 2009
Copyright:Public Domain

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/10/2014

pdf

text

original

Table\ue000 of\ue000 Contents
\ue000\ue000
UNITED\ue000 STATES
SECURITIES\ue000 AND\ue000 EXCHANGE\ue000 COMMISSION
Washington,\ue000 D.C.\ue000 20549
\ue000
\ue000
FORM\ue000 10-K
\ue000
\ue000
FOR\ue000 ANNUAL\ue000 AND\ue000 TRANSITION\ue000 REPORTS\ue000 PURSUANT\ue000 TO\ue000 SECTIONS\ue000 13\ue000 OR\ue000 15(d)
OF\ue000 THE\ue000 SECURITIES\ue000 EXCHANGE\ue000 ACT\ue000 OF\ue000 1934
(Mark\ue000 one)
\ue000
\ue000
x
ANNUAL\ue000 REPORT\ue000 PURSUANT\ue000 TO\ue000 SECTION\ue000 13\ue000 OR\ue000 15(d)\ue000 OF\ue000 THE\ue000 SECURITIES\ue000 EXCHANGE\ue000 ACT\ue000 OF\ue000 1934
\ue000
\ue000
\ue000\ue000\ue000\ue000
For\ue000 the\ue000 fiscal\ue000 year\ue000 ended\ue000 December\ue000 31,\ue000 2008
OR
\ue000
\ue000
\u00ae
TRANSITION\ue000 REPORT\ue000 PURSUANT\ue000 TO\ue000 SECTION\ue000 13\ue000 OR\ue000 15(d)\ue000 OF\ue000 THE\ue000 SECURITIES\ue000 EXCHANGE\ue000 ACT\ue000 OF
1934\ue000 FOR\ue000 THE\ue000 TRANSITION\ue000 PERIOD\ue000 FROM\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000 TO\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000\ue000
Commission\ue000 File\ue000 Number\ue000 0-19946
\ue000
Lincare\ue000 Holdings\ue000 Inc.
(Exact\ue000 name\ue000 of\ue000 registrant\ue000 as\ue000 specified\ue000 in\ue000 its\ue000 charter)
\ue000
Delaware
\ue000
51-0331330
(State\ue000 or\ue000 other\ue000 jurisdiction
of\ue000 incorporation\ue000 or\ue000 organization)
\ue000
(I.R.S.\ue000 Employer
Identification\ue000 Number)
19387\ue000 US\ue000 19\ue000 North\ue000 Clearwater,\ue000 Florida
\ue000
33764
(Address\ue000 of\ue000 principal\ue000 executive\ue000 office)
\ue000
(Zip\ue000 Code)
Registrant\u2019s\ue000 telephone\ue000 number,\ue000 including\ue000 area\ue000 code:
(727)\ue000 530-7700
Securities\ue000 registered\ue000 pursuant\ue000 to\ue000 Section\ue000 12(b)\ue000 of\ue000 the\ue000 Act:
None
Securities\ue000 registered\ue000 pursuant\ue000 to\ue000 Section\ue000 12(g)\ue000 of\ue000 the\ue000 Act:
Common\ue000 Stock,\ue000 $.01\ue000 par\ue000 value\ue000 per\ue000 share
\ue000
\ue000

Indicate\ue000 by\ue000 check\ue000 mark\ue000 if\ue000 the\ue000 Registrant\ue000 is\ue000 a\ue000 well-known\ue000 seasoned\ue000 issuer,\ue000 as\ue000 defined\ue000 in\ue000 Rule\ue000 405\ue000 of\ue000 the\ue000 Securities\ue000 Act.\ue000 Yes\ue000 \ue000x\ue000\ue000\ue000\ue000 No\ue000 \ue000\u00ae Indicate\ue000 by\ue000 check\ue000 mark\ue000 if\ue000 the\ue000 Registrant\ue000 is\ue000 not\ue000 required\ue000 to\ue000 file\ue000 reports\ue000 pursuant\ue000 to\ue000 Section\ue000 13\ue000 or\ue000 Section\ue000 15(d)\ue000 of\ue000 the\ue000 Act.\ue000 Yes\ue000 \ue000\u00ae\ue000\ue000\ue000\ue000 No\ue000 \ue000x Indicate\ue000 by\ue000 check\ue000 mark\ue000 whether\ue000 the\ue000 registrant:\ue000 (1)\ue000 has\ue000 filed\ue000 all\ue000 reports\ue000 required\ue000 to\ue000 be\ue000 filed\ue000 by\ue000 Section\ue000 13\ue000 or\ue000 15(d)\ue000 of\ue000 the\ue000 Securities

Exchange\ue000 Act\ue000 of\ue000 1934\ue000 during\ue000 the\ue000 preceding\ue000 12\ue000 months\ue000 (or\ue000 for\ue000 such\ue000 shorter\ue000 period\ue000 that\ue000 the\ue000 registrant\ue000 was\ue000 required\ue000 to\ue000 file\ue000 such\ue000 reports),\ue000 and
(2)\ue000 has\ue000 been\ue000 subject\ue000 to\ue000 such\ue000 filing\ue000 requirements\ue000 for\ue000 the\ue000 past\ue000 90\ue000 days.\ue000 Yes\ue000 \ue000x\ue000\ue000\ue000\ue000 No\ue000 \ue000\u00ae

Indicate\ue000 by\ue000 check\ue000 mark\ue000 if\ue000 disclosure\ue000 of\ue000 delinquent\ue000 filers\ue000 pursuant\ue000 to\ue000 Item\ue000 405\ue000 of\ue000 Regulation\ue000 S-K\ue000 is\ue000 not\ue000 contained\ue000 herein,\ue000 and\ue000 will\ue000 not\ue000 be contained,\ue000 to\ue000 the\ue000 best\ue000 of\ue000 registrant\u2019s\ue000 knowledge,\ue000 in\ue000 definitive\ue000 proxy\ue000 or\ue000 information\ue000 statements\ue000 incorporated\ue000 by\ue000 reference\ue000 in\ue000 Part\ue000 III\ue000 of\ue000 this\ue000 Form 10-K\ue000 or\ue000 any\ue000 amendment\ue000 to\ue000 this\ue000 Form\ue000 10-K.\ue000 \ue000x

Indicate\ue000 by\ue000 check\ue000 mark\ue000 whether\ue000 the\ue000 registrant\ue000 is\ue000 a\ue000 large\ue000 accelerated\ue000 filer,\ue000 an\ue000 accelerated\ue000 filer,\ue000 or\ue000 non-accelerated\ue000 filer,\ue000 or\ue000 a\ue000 smaller reporting\ue000 company.\ue000 See\ue000 definitions\ue000 of\ue000 \u201clarge\ue000 accelerated\ue000 filer,\u201d\ue000 \u201caccelerated\ue000 filer,\u201d\ue000 and\ue000 \u201csmaller\ue000 reporting\ue000 company\u201d\ue000 in\ue000 Rule\ue000 12b-2\ue000 of\ue000 the Exchange\ue000 Act.\ue000 (Check\ue000 one):

\ue000
Large\ue000 accelerated\ue000 filer\ue000\ue000\ue000\ue000x \ue000\ue000\ue000\ue000 Accelerated\ue000 filer\ue000\ue000\ue000\ue000\u00ae \ue000\ue000\ue000\ue000 Non-accelerated\ue000 filer\ue000\ue000\ue000\ue000\u00ae \ue000\ue000\ue000\ue000 Smaller\ue000 reporting\ue000 company\ue000\ue000\ue000\ue000\u00ae

(Do\ue000 not\ue000 check\ue000 if\ue000 a\ue000 smaller\ue000 reporting\ue000 company)
Indicate\ue000 by\ue000 check\ue000 mark\ue000 whether\ue000 the\ue000 registrant\ue000 is\ue000 a\ue000 shell\ue000 company\ue000 (as\ue000 defined\ue000 in\ue000 Exchange\ue000 Act\ue000 Rule\ue000 12b-2).\ue000 Yes\ue000 \ue000\u00ae\ue000\ue000\ue000\ue000\ue000 No\ue000 \ue000x
The\ue000 aggregate\ue000 market\ue000 value\ue000 of\ue000 the\ue000 registrant\u2019s\ue000 common\ue000 stock,\ue000 $.01\ue000 par\ue000 value,\ue000 held\ue000 by\ue000 non-affiliates\ue000 of\ue000 the\ue000 registrant,\ue000 based\ue000 on\ue000 a\ue000 $28.40

closing\ue000 sale\ue000 price\ue000 of\ue000 the\ue000 common\ue000 stock\ue000 on\ue000 June\ue000 30,\ue000 2008,\ue000 as\ue000 reported\ue000 on\ue000 the\ue000 NASDAQ\ue000 National\ue000 Market\ue000 System,\ue000 was\ue000 approximately
$2,069,759,056.
As\ue000 of\ue000 January\ue000 31,\ue000 2009,\ue000 there\ue000 were\ue000 74,393,068\ue000 outstanding\ue000 shares\ue000 of\ue000 the\ue000 registrant\u2019s\ue000 common\ue000 stock,\ue000 par\ue000 value\ue000 $.01,\ue000 which\ue000 is\ue000 the\ue000 only\ue000 class
of\ue000 capital\ue000 stock\ue000 of\ue000 the\ue000 registrant\ue000 outstanding.
DOCUMENTS\ue000 INCORPORATED\ue000 BY\ue000 REFERENCE

Certain\ue000 information\ue000 called\ue000 for\ue000 by\ue000 Part\ue000 III\ue000 of\ue000 this\ue000 Form\ue000 10-K\ue000 is\ue000 incorporated\ue000 by\ue000 reference\ue000 to\ue000 the\ue000 definitive\ue000 Proxy\ue000 Statement\ue000 for\ue000 the\ue000 2009
Annual\ue000 Meeting\ue000 of\ue000 Stockholders\ue000 of\ue000 Lincare\ue000 Holdings\ue000 Inc.,\ue000 which\ue000 will\ue000 be\ue000 filed\ue000 with\ue000 the\ue000 Securities\ue000 and\ue000 Exchange\ue000 Commission\ue000 not\ue000 later\ue000 than\ue000 120
days\ue000 after\ue000 December\ue000 31,\ue000 2008.

\ue000
\ue000\ue000
Processed and formatted by SEC Watch - Visit SECWatch.com
Table\ue000 of\ue000 Contents
LINCARE\ue000 HOLDINGS\ue000 INC.\ue000 AND\ue000 SUBSIDIARIES
FORM\ue000 10-K
For\ue000 The\ue000 Year\ue000 Ended\ue000 December\ue000 31,\ue000 2008
INDEX
\ue000
\ue000
\ue000\ue000 \ue000
\ue000\ue000Page
\ue000\ue000
PART\ue000 I.
\ue000\ue000
Item\ue000 1.
\ue000\ue000Business
\ue000\ue000
1
Item\ue000 1A.
\ue000\ue000Risk\ue000 Factors
\ue000\ue000
9
Item\ue000 1B.
\ue000\ue000Unresolved\ue000 Staff\ue000 Comments
\ue000\ue000
16
Item\ue000 2.
\ue000\ue000Properties
\ue000\ue000
16
Item\ue000 3.
\ue000\ue000Legal\ue000 Proceedings
\ue000\ue000
16
Item\ue000 4.
\ue000\ue000Submission\ue000 of\ue000 Matters\ue000 to\ue000 a\ue000 Vote\ue000 of\ue000 Security\ue000 Holders
\ue000\ue000
17
\ue000\ue000
PART\ue000 II.
\ue000\ue000
Item\ue000 5.
\ue000\ue000Market\ue000 for\ue000 Registrant\u2019s\ue000 Common\ue000 Equity,\ue000 Related\ue000 Stockholder\ue000 Matters\ue000 and\ue000 Issuer\ue000 Purchases\ue000 of\ue000 Equity\ue000 Securities
\ue000\ue000
18
Item\ue000 6.
\ue000\ue000Selected\ue000 Financial\ue000 Data
\ue000\ue000
21
Item\ue000 7.
\ue000\ue000Management\u2019s\ue000 Discussion\ue000 and\ue000 Analysis\ue000 of\ue000 Financial\ue000 Condition\ue000 and\ue000 Results\ue000 of\ue000 Operations
\ue000\ue000
22
Item\ue000 7A.
\ue000\ue000Quantitative\ue000 and\ue000 Qualitative\ue000 Disclosures\ue000 About\ue000 Market\ue000 Risk
\ue000\ue000
37
Item\ue000 8.
\ue000\ue000Financial\ue000 Statements\ue000 and\ue000 Supplementary\ue000 Data
\ue000\ue000
37
Item\ue000 9.
\ue000\ue000Changes\ue000 in\ue000 and\ue000 Disagreements\ue000 With\ue000 Accountants\ue000 on\ue000 Accounting\ue000 and\ue000 Financial\ue000 Disclosure
\ue000\ue000
38
Item\ue000 9A.
\ue000\ue000Controls\ue000 and\ue000 Procedures
\ue000\ue000
38
Item\ue000 9B.
\ue000\ue000Other\ue000 Information
\ue000\ue000
40
\ue000\ue000
PART\ue000 III.
\ue000\ue000
Item\ue000 10.
\ue000\ue000Directors,\ue000 Executive\ue000 Officers\ue000 and\ue000 Corporate\ue000 Governance
\ue000\ue000
41
Item\ue000 11.
\ue000\ue000Executive\ue000 Compensation
\ue000\ue000
41
Item\ue000 12.
\ue000\ue000Security\ue000 Ownership\ue000 of\ue000 Certain\ue000 Beneficial\ue000 Owners\ue000 and\ue000 Management\ue000 and\ue000 Related\ue000 Stockholder\ue000 Matters
\ue000\ue000
41
Item\ue000 13.
\ue000\ue000Certain\ue000 Relationships\ue000 and\ue000 Related\ue000 Transactions,\ue000 and\ue000 Director\ue000 Independence
\ue000\ue000
42
Item\ue000 14.
\ue000\ue000Principal\ue000 Accountant\ue000 Fees\ue000 and\ue000 Services
\ue000\ue000
42
\ue000\ue000
PART\ue000 IV.
\ue000\ue000
Item\ue000 15.
\ue000\ue000Exhibits\ue000 and\ue000 Financial\ue000 Statement\ue000 Schedules
\ue000\ue000
43
Signatures
\ue000\ue000
44
Index\ue000 of\ue000 Exhibits
\ue000\ue000
S-2
Processed and formatted by SEC Watch - Visit SECWatch.com
Table\ue000 of\ue000 Contents
PART\ue000 I
Item\ue000 1.\ue000\ue000\ue000\ue000Business
General

Lincare\ue000 Holdings\ue000 Inc.,\ue000 together\ue000 with\ue000 its\ue000 subsidiaries\ue000 (\u201cLincare,\u201d\ue000 the\ue000 \u201cCompany,\u201d\ue000 \u201cwe\u201d\ue000 or\ue000 \u201cour\u201d),\ue000 is\ue000 one\ue000 of\ue000 the\ue000 nation\u2019s\ue000 largest\ue000 providers of\ue000 oxygen\ue000 and\ue000 other\ue000 respiratory\ue000 therapy\ue000 services\ue000 to\ue000 patients\ue000 in\ue000 the\ue000 home.\ue000 Our\ue000 customers\ue000 typically\ue000 suffer\ue000 from\ue000 chronic\ue000 obstructive\ue000 pulmonary disease\ue000 (\u201cCOPD\u201d),\ue000 such\ue000 as\ue000 emphysema,\ue000 chronic\ue000 bronchitis\ue000 or\ue000 asthma,\ue000 and\ue000 require\ue000 supplemental\ue000 oxygen\ue000 or\ue000 other\ue000 respiratory\ue000 therapy\ue000 services in\ue000 order\ue000 to\ue000 alleviate\ue000 the\ue000 symptoms\ue000 and\ue000 discomfort\ue000 of\ue000 respiratory\ue000 dysfunction.\ue000 Lincare\ue000 currently\ue000 serves\ue000 approximately\ue000 700,000\ue000 customers\ue000 in\ue000 48 states\ue000 through\ue000 1,063\ue000 operating\ue000 centers.\ue000 Lincare\ue000 Holdings\ue000 Inc.\ue000 was\ue000 incorporated\ue000 in\ue000 Delaware\ue000 in\ue000 1990.\ue000 Our\ue000 principal\ue000 executive\ue000 offices\ue000 are\ue000 located at\ue000 19387\ue000 U.S.\ue000 Hwy\ue000 19\ue000 North,\ue000 Clearwater,\ue000 Florida\ue000 33764,\ue000 and\ue000 our\ue000 telephone\ue000 number\ue000 is\ue000 (727)\ue000 530-7700.

The\ue000 Home\ue000 Respiratory\ue000 Market

We\ue000 estimate\ue000 that\ue000 the\ue000 home\ue000 respiratory\ue000 market\ue000 (including\ue000 home\ue000 oxygen\ue000 equipment\ue000 and\ue000 respiratory\ue000 therapy\ue000 services)\ue000 represents\ue000 in\ue000 excess
of\ue000 $6.0\ue000 billion\ue000 in\ue000 annual\ue000 sales.\ue000 Growth\ue000 in\ue000 the\ue000 home\ue000 respiratory\ue000 market\ue000 is\ue000 driven\ue000 by\ue000 increases\ue000 in\ue000 the\ue000 number\ue000 of\ue000 persons\ue000 afflicted\ue000 with\ue000 COPD,
demographic\ue000 factors\ue000 that\ue000 contribute\ue000 to\ue000 an\ue000 increase\ue000 in\ue000 the\ue000 proportion\ue000 of\ue000 the\ue000 U.S.\ue000 population\ue000 over\ue000 the\ue000 age\ue000 of\ue000 65\ue000 years,\ue000 and\ue000 the\ue000 continued\ue000 trend
toward\ue000 treatment\ue000 of\ue000 patients\ue000 in\ue000 the\ue000 home\ue000 as\ue000 a\ue000 lower\ue000 cost\ue000 alternative\ue000 to\ue000 the\ue000 acute\ue000 care\ue000 setting.

Business\ue000 Strategy

Our\ue000 strategy\ue000 is\ue000 to\ue000 increase\ue000 our\ue000 market\ue000 share\ue000 through\ue000 internal\ue000 growth\ue000 and\ue000 strategic\ue000 business\ue000 acquisitions.\ue000 Lincare\ue000 achieves\ue000 internal
growth\ue000 in\ue000 existing\ue000 geographic\ue000 markets\ue000 through\ue000 the\ue000 addition\ue000 of\ue000 new\ue000 customers\ue000 and\ue000 referral\ue000 sources\ue000 to\ue000 our\ue000 network\ue000 of\ue000 local\ue000 operating\ue000 centers.\ue000 In
addition,\ue000 we\ue000 expand\ue000 into\ue000 new\ue000 geographic\ue000 markets\ue000 on\ue000 a\ue000 selective\ue000 basis,\ue000 either\ue000 through\ue000 acquisitions\ue000 or\ue000 by\ue000 opening\ue000 new\ue000 operating\ue000 centers,\ue000 when
we\ue000 believe\ue000 such\ue000 expansion\ue000 will\ue000 enhance\ue000 our\ue000 business.\ue000 In\ue000 2008,\ue000 Lincare\ue000 acquired\ue000 three\ue000 local\ue000 and\ue000 regional\ue000 companies\ue000 with\ue000 operations\ue000 in\ue000 multiple

states.

Revenue\ue000 growth\ue000 is\ue000 dependent\ue000 upon\ue000 the\ue000 overall\ue000 growth\ue000 rate\ue000 of\ue000 the\ue000 home\ue000 respiratory\ue000 market\ue000 and\ue000 on\ue000 our\ue000 ability\ue000 to\ue000 increase\ue000 market\ue000 share
through\ue000 effective\ue000 delivery\ue000 of\ue000 high\ue000 quality\ue000 equipment\ue000 and\ue000 services\ue000 and\ue000 selective\ue000 business\ue000 acquisitions.\ue000 Continued\ue000 cost\ue000 containment\ue000 efforts\ue000 by
government\ue000 and\ue000 private\ue000 insurance\ue000 reimbursement\ue000 programs\ue000 have\ue000 created\ue000 an\ue000 increasingly\ue000 competitive\ue000 environment,\ue000 accelerating\ue000 consolidation
trends\ue000 within\ue000 the\ue000 home\ue000 health\ue000 care\ue000 industry.

We\ue000 will\ue000 continue\ue000 our\ue000 focus\ue000 on\ue000 providing\ue000 oxygen\ue000 and\ue000 other\ue000 respiratory\ue000 therapy\ue000 services\ue000 to\ue000 patients\ue000 in\ue000 the\ue000 home\ue000 and\ue000 to\ue000 provide\ue000 home
medical\ue000 equipment\ue000 and\ue000 other\ue000 services\ue000 where\ue000 we\ue000 believe\ue000 such\ue000 services\ue000 will\ue000 enhance\ue000 our\ue000 primary\ue000 business.\ue000 In\ue000 2008,\ue000 oxygen\ue000 and\ue000 other\ue000 respiratory
therapy\ue000 services\ue000 accounted\ue000 for\ue000 approximately\ue000 92%\ue000 of\ue000 Lincare\u2019s\ue000 net\ue000 revenues.

Products\ue000 and\ue000 Services\ue000 of\ue000 Lincare

Lincare\ue000 primarily\ue000 provides\ue000 oxygen\ue000 and\ue000 other\ue000 respiratory\ue000 therapy\ue000 services\ue000 to\ue000 patients\ue000 in\ue000 the\ue000 home.\ue000 We\ue000 also\ue000 provide\ue000 a\ue000 variety\ue000 of\ue000 durable
medical\ue000 equipment\ue000 (\u201cDME\u201d)\ue000 and\ue000 home\ue000 infusion\ue000 therapies\ue000 in\ue000 certain\ue000 geographic\ue000 markets.\ue000 When\ue000 a\ue000 physician,\ue000 hospital\ue000 discharge\ue000 planner,\ue000 or
other\ue000 source\ue000 refers\ue000 a\ue000 patient\ue000 to\ue000 one\ue000 of\ue000 our\ue000 operating\ue000 centers,\ue000 our\ue000 customer\ue000 representative\ue000 obtains\ue000 the\ue000 necessary\ue000 medical\ue000 and\ue000 insurance
coverage\ue000 information\ue000 and\ue000 assignment\ue000 of\ue000 benefits\ue000 to\ue000 Lincare,\ue000 and\ue000 coordinates\ue000 the\ue000 delivery\ue000 of\ue000 patient\ue000 care.\ue000 The\ue000 prescribed\ue000 therapy\ue000 is\ue000 delivered
by\ue000 one\ue000 of\ue000 our\ue000 service\ue000 representatives\ue000 or\ue000 clinicians\ue000 at\ue000 the\ue000 customer\u2019s\ue000 home,\ue000 where\ue000 instruction\ue000 and\ue000 training\ue000 are\ue000 provided\ue000 to\ue000 the\ue000 customer\ue000 and\ue000 the
customer\u2019s\ue000 family\ue000 regarding\ue000 appropriate\ue000 equipment\ue000 use\ue000 and\ue000 maintenance\ue000 and\ue000 compliance\ue000 with\ue000 the\ue000 prescribed\ue000 therapy.\ue000 Following\ue000 the\ue000 initial
setup,\ue000 our\ue000 service\ue000 representatives\ue000 and/or\ue000 clinicians\ue000 make\ue000 periodic\ue000 visits\ue000 to\ue000 the\ue000 customer\u2019s\ue000 home,\ue000 the\ue000 frequency\ue000 of\ue000 which\ue000 is\ue000 dictated\ue000 by\ue000 the\ue000 type
of\ue000 therapy\ue000 prescribed\ue000 and\ue000 physician\ue000 orders.\ue000 All\ue000 services\ue000 and\ue000 equipment\ue000 provided\ue000 by\ue000 Lincare\ue000 are\ue000 coordinated\ue000 with

\ue000
1
Processed and formatted by SEC Watch - Visit SECWatch.com

Activity (2)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->